ADIAL PHARMACEUTICALS, INC.

Adial Pharmaceuticals, Inc.

Biotechnology • Healthcare • Glen Allen, VA, United States • ADIL (NCM)

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Adial (NASDAQ: ADIL) outlines 2026 cash runway and FDA End of Phase 2 guidance for lead drug - Stock Titan
Stock Titan • Nov 14
Maxim Group Upgrades Adial Pharmaceuticals (ADIL) - Nasdaq
Nasdaq • Sep 30
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Yahoo Finance • Jul 10
Adial Pharmaceuticals Granted a 180 Calendar Day Extension - GlobeNewswire
GlobeNewswire • Sep 3
Adial Pharmaceuticals shareholders approve share increases and board proposals - Investing.com
Investing.com • Aug 1

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has ADIAL PHARMACEUTICALS, INC. had layoffs?
No layoff events have been recorded for ADIAL PHARMACEUTICALS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does ADIAL PHARMACEUTICALS, INC. have?
ADIAL PHARMACEUTICALS, INC. has approximately 5 employees.
What industry is ADIAL PHARMACEUTICALS, INC. in?
ADIAL PHARMACEUTICALS, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is ADIAL PHARMACEUTICALS, INC. a publicly traded company?
Yes, ADIAL PHARMACEUTICALS, INC. is publicly traded under the ticker symbol ADIL on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is ADIAL PHARMACEUTICALS, INC. headquartered?
ADIAL PHARMACEUTICALS, INC. is headquartered in Glen Allen, VA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.